Back to Results

Butterfly Network, Inc (BFLY)

Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks

Butterfly Network, Inc. is a healthcare equipment company focused on ultrasound imaging solutions in the United States and abroad. The company develops and commercializes handheld and cart-based imaging products, including Butterfly iQ+ and iQ3, which are designed to support whole-body scanning through a single probe that can connect with smartphones, tablets, and many hospital computer systems. Its product lineup also includes Butterfly Move, iQ+ Bladder for bladder scanning, and the Butterfly iQ+/iQ3 Vet system for veterinary use. In addition, Butterfly Network provides Compass AI, a platform intended to connect devices and workflows, and ScanLab, an AI-enabled educational tool that supports real-time scanning practice. The company uses direct sales, distributors, and e-commerce channels to market its products. Butterfly Network was founded in 2011 and is headquartered in Burlington, Massachusetts.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-BFLY
$4.14
-38.5% Downside
Overvalued
$7.06
4.8% Upside
Fair
Fair
—
—
—
0.0%
July 30, 2026
-23.2x
9.2x
17.1x
1.75 B
1.641 B
1.1%
74.1%
7.1
—
24.9%
Send a message
Valuation • Fair Value

Butterfly Network, Inc (NYSE-BFLY) Fair Value by Valuation Model

Compare the primary fair value estimate for Butterfly Network, Inc (NYSE-BFLY) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$4.14

Estimated downside of 38.5% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$3.64

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$4.40

Comparable-company valuation reference.

Analyst Price Target

$7.06

Analysts imply upside of 4.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Butterfly Network, Inc (NYSE-BFLY) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Butterfly Network, Inc (NYSE-BFLY)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

102.9 M

Current operating scale indicator.

Revenue Forecast

118.5 M

Forward revenue estimate.

EBITDA

-50.431 M

Current operating profitability reference.

EBITDA Forecast

-23.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Butterfly Network, Inc (NYSE-BFLY) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Butterfly Network, Inc (NYSE-BFLY)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.51

No elevated caution signal from this screen.

Altman Z-Score

7.1

Relatively strong balance-sheet zone.

FCF / Net Income

24.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Butterfly Network, Inc (NYSE-BFLY). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Butterfly Network, Inc (NYSE-BFLY)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Butterfly Network, Inc (NYSE-BFLY), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Butterfly Network, Inc (NYSE-BFLY) Stock Forecast & Technical Outlook

Review Butterfly Network, Inc (NYSE-BFLY) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Butterfly Network, Inc (NYSE-BFLY) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Butterfly Network, Inc (NYSE-BFLY) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Butterfly Network, Inc (NYSE-BFLY) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Butterfly Network, Inc (NYSE-BFLY) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Butterfly Network, Inc (NYSE-BFLY) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Butterfly Network, Inc (NYSE-BFLY)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Butterfly Network, Inc (NYSE-BFLY) has a Strong Buy consensus, with 5 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 0
Sell 0
FAQ • Fast Investor Answers

Butterfly Network, Inc (NYSE-BFLY) Stock FAQ

Quick answers about Butterfly Network, Inc (NYSE-BFLY) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$4.14
Estimated downside 38.5%
Valuation Rating
Overvalued
Estimated downside of 38.5%
Analyst Target
$7.06
Implied upside 4.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Butterfly Network, Inc (NYSE-BFLY) is $4.14. This implies an estimated downside of 38.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 38.5% versus the current market price.

The available analyst price target for Butterfly Network, Inc (NYSE-BFLY) is $7.06. The analyst target implies estimated upside of 4.8%.

The current financial health read for Butterfly Network, Inc (NYSE-BFLY) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Butterfly Network, Inc (NYSE-BFLY) is July 30, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Butterfly Network, Inc (NYSE-BFLY) is -23.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Butterfly Network, Inc is 1.75 B.

The current enterprise value listed for Butterfly Network, Inc is 1.641 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Butterfly Network, Inc is NYSE-BFLY, and the stock is listed on NYSE.

Butterfly Network, Inc (NYSE-BFLY) is listed on NYSE.

The current debt-to-total-capital ratio listed for Butterfly Network, Inc is 1.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Butterfly Network, Inc is 74.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks on NYSE View more

Abbott Laboratories (ABT) Abbott Laboratories (ABT)
Stryker Corporation (SYK) Stryker Corporation (SYK)
Medtronic PLC (MDT) Medtronic PLC (MDT)
Boston Scientific Corp (BSX) Boston Scientific Corp (BSX)
Edwards Lifesciences Corp (EW) Edwards Lifesciences Corp (EW)
Becton Dickinson and Co (BDX) Becton Dickinson and Co (BDX)
Alcon AG (ALC) Alcon AG (ALC)
ResMed Inc (RMD) ResMed Inc (RMD)
Koninklijke Philips NV ADR (PHG) Koninklijke Philips NV ADR (PHG)
STERIS plc (STE) STERIS plc (STE)
Zimmer Biomet Holdings Inc (ZBH) Zimmer Biomet Holdings Inc (ZBH)
Solventum Corp (SOLV) Solventum Corp (SOLV)
Smith & Nephew SNATS Inc (SNN) Smith & Nephew SNATS Inc (SNN)
Penumbra Inc (PEN) Penumbra Inc (PEN)
Baxter International Inc (BAX) Baxter International Inc (BAX)
Globus Medical (GMED) Globus Medical (GMED)
Glaukos Corp (GKOS) Glaukos Corp (GKOS)
Teleflex Incorporated (TFX) Teleflex Incorporated (TFX)
Bausch + Lomb Corp (BLCO) Bausch + Lomb Corp (BLCO)
Envista Holdings Corp (NVST) Envista Holdings Corp (NVST)
Haemonetics Corporation (HAE) Haemonetics Corporation (HAE)
Integer Holdings Corp (ITGR) Integer Holdings Corp (ITGR)
Enovis Corp (ENOV) Enovis Corp (ENOV)
Inspire Medical Systems Inc (INSP) Inspire Medical Systems Inc (INSP)